DUBLIN–(BUSINESS WIRE)–The “Biomarkers: Technologies and Global Markets 2021” report has been added to ResearchAndMarkets.com’s offering.
This new report provides a comprehensive analysis of the biomarkers market in a global context, including market forecasts and sales through 2025. The report analyzes the market, segmenting it into various product offerings (i.e., instruments, consumables [reagents, kits and panels], services and software). Segmentation also provides analysis by popular technology type (genomics, proteomics and metabolomics, imaging and bioinformatics).
This study surveys the biomarker market by therapeutic area (cancer, cardiovascular and metabolic diseases, infectious diseases, neurodegenerative diseases, autoimmune diseases and others. End-users include academic institutes, pharma and biotechnology companies, clinical research organizations, hospitals and diagnostics. Geographic regions include North America, Europe and Emerging markets. Emerging markets include countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, etc.
This report features new product developments and patents that are boosting global growth in this market. This report provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on changing market trends, market players and leading products. This chapter also covers mergers and acquisitions and other collaborations or partnerships that are expected to shape the industry.
Strengths, weaknesses, threats and opportunities are expected to play a role in the diagnostic biomarkers market. These are evaluated in detail. The scope of the report excludes in vitro diagnostic products and regulatory aspects. Digital biomarkers are not covered in this report.
Companies Mentioned
- 10X Genomics
- Abbott Laboratories Ltd.
- Abcam Plc
- Agilent Technologies Inc.
- Bayer Ag
- Beckman Coulter Life Sciences
- Becton Dickinson & Co.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corp.
- Biolegend
- Bruker Corp.
- Canon Medical Systems Corp.
- Cepheid
- Creative Proteomics
- Cubresa Inc.
- Cytiva
- Danaher Corp.
- F Hoffmann-La Roche Ag
- Fujifilm Visual Sonics Inc.
- GE Healthcare
- Illumina Inc.
- Integrated DNA Technologies (IDT)
- Jeol Ltd.
- Koninklijke Philips N.V.
- Lantheus Medical Imaging Inc.
- Leco Corp.
- Leica Biosystems
- Luminex Corp.
- Metabolon Inc.
- Millipore Sigma
- Molecular Devices
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences Inc.
- Perkinelmer Inc.
- Promega Corp.
- Qiagen N.V.
- Quanterix Corp.
- Sciex
- Shimadzu Corp.
- Siemens Healthineer Ag
- Thermo Fisher Scientific Inc.
- Waters Corp.
Report Includes:
- 48 data tables and 25 additional tables
- An updated review and current landscape of the global biomarkers market
- Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Estimation of market size and market potential for global biomarkers market, and corresponding market share analysis by product type, technology type, therapeutic area, end-user and geographic region for each market segment
- Latest information on market opportunities and drivers, industry structure, regulatory frameworks, clinical trials and technological updates which are affecting the overall market growth
- Identification of the leading biotechnology companies poised to introduce products during the forecast period, their impact on the face of the competitive environment and research priorities
- Encompassing details of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics
- Review of patents issued for biomarker technologies and deep dive of the patent data by year, technology type, application, company, assignee and applicant country
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
- Key Highlights
Chapter 3 Market and Technology Background
- Definitions of Biomarkers
- Classification of Biomarkers
- Examples of Biomarkers
- Surrogate Biomarkers/Endpoints
- Types of Biomarkers
- Molecular Biomarkers
- Imaging Biomarkers
- Biomarker Discovery, Verification and Validation
- Biomarker Discovery and Development
- Biomarker Verification
- Biomarker Validation
- Clinical Implementation
- Biomarker Qualification
- Technologies Used in Biomarker Analysis
- Genomics
- Proteomics
- Metabolomics
- Imaging
- Bioinformatics
- Applications of Biomarkers
- Diagnostics, Therapeutics and Disease Monitoring
- Drug Discovery and Development
- Clinical Trials
- Personalized Medicine
Chapter 4 Market Breakdown by Product Type
Chapter 5 Market Breakdown by Technology Type
Chapter 6 Market Breakdown by Therapeutic Area
Chapter 7 Market Breakdown by End User
Chapter 8 Industry Structure
- Industry Trends
- Collaborations and Partnerships
- License Agreements
- Mergers and Acquisitions
- Leading Manufacturers/Suppliers of Biomarkers Technologies
- Genomics
- Proteomics
- Metabolomics
- Imaging
- Bioinformatics
Chapter 9 Clinical Trials
- Clinical Trials by Therapeutic Area
- Clinical Trials by Study Status
- Clinical Trials by Study Phase
- Clinical Trials of Studies including Children
- Clinical Trials by Country
- Clinical Trials by Sponsor
Chapter 10 Patent Analysis
- Patents on Biomarkers
- Case Studies
- Case Study: Association for Molecular Pathology v. Myriad Genetics Inc.
- Case Study: Roche Molecular Systems Inc. v. Cepheid
- Patent Analysis
- Patents by Year
- Patents by Type
- Patents by Application
- Patents by Company
- Patents, by Country
- Patents by Type of Assignee
Chapter 11 Analysis of Market Opportunities
Chapter 12 Company Profiles
Chapter 13 Appendix: Abbreviations/Acronyms
For more information about this report visit https://www.researchandmarkets.com/r/de2ldy
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900